Cutting-Edge Infectious Disease Diagnostics with CRISPR

Three recent Science articles (Chen et al., 2018, Gootenberg et al., 2018, Myhrvold et al., 2018) describe the use of CRISPR-Cas technology to develop point-of-care diagnostics that directly detect viruses from clinical samples. These tests could radically transform approaches to diagnosing infectio...

Descripción completa

Detalles Bibliográficos
Autor principal: Chiu, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105017/
https://www.ncbi.nlm.nih.gov/pubmed/29902435
http://dx.doi.org/10.1016/j.chom.2018.05.016
_version_ 1783512324654497792
author Chiu, Charles
author_facet Chiu, Charles
author_sort Chiu, Charles
collection PubMed
description Three recent Science articles (Chen et al., 2018, Gootenberg et al., 2018, Myhrvold et al., 2018) describe the use of CRISPR-Cas technology to develop point-of-care diagnostics that directly detect viruses from clinical samples. These tests could radically transform approaches to diagnosing infectious diseases at the bedside and in the field.
format Online
Article
Text
id pubmed-7105017
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71050172020-03-31 Cutting-Edge Infectious Disease Diagnostics with CRISPR Chiu, Charles Cell Host Microbe Article Three recent Science articles (Chen et al., 2018, Gootenberg et al., 2018, Myhrvold et al., 2018) describe the use of CRISPR-Cas technology to develop point-of-care diagnostics that directly detect viruses from clinical samples. These tests could radically transform approaches to diagnosing infectious diseases at the bedside and in the field. Elsevier Inc. 2018-06-13 2018-06-13 /pmc/articles/PMC7105017/ /pubmed/29902435 http://dx.doi.org/10.1016/j.chom.2018.05.016 Text en © 2018 Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Chiu, Charles
Cutting-Edge Infectious Disease Diagnostics with CRISPR
title Cutting-Edge Infectious Disease Diagnostics with CRISPR
title_full Cutting-Edge Infectious Disease Diagnostics with CRISPR
title_fullStr Cutting-Edge Infectious Disease Diagnostics with CRISPR
title_full_unstemmed Cutting-Edge Infectious Disease Diagnostics with CRISPR
title_short Cutting-Edge Infectious Disease Diagnostics with CRISPR
title_sort cutting-edge infectious disease diagnostics with crispr
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7105017/
https://www.ncbi.nlm.nih.gov/pubmed/29902435
http://dx.doi.org/10.1016/j.chom.2018.05.016
work_keys_str_mv AT chiucharles cuttingedgeinfectiousdiseasediagnosticswithcrispr

Ejemplares similares